The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients
{{output}}
Recombinant factor VIIa (rFVIIa, NovoSeven) is effective and appears safe in the management of bleeding episodes and provision of surgical cover in haemophilia patients with inhibitors. Additionally, rFVIIa has been considered as a universal haemostatic agent,... ...
